Combinatorial biosynthesis of lipopeptide antibiotics in Streptomyces roseosporus

Daptomycin is a cyclic lipopeptide antibiotic produced by Streptomyces roseosporus. Cubicin® (daptomycin-for-injection) was approved in 2003 by the FDA to treat skin and skin structure infections caused by Gram-positive pathogens. Daptomycin is particularly significant in that it represents the first new natural product antibacterial structural class approved for clinical use in three decades. The daptomycin gene cluster contains three very large genes (dptA, dptBC, and dptD) that encode the nonribosomal peptide synthetase (NRPS). The related cyclic lipopeptide A54145 has four NRPS genes (lptA, lptB, lptC, and lptD), and calcium dependent antibiotic (CDA) has three (cdaPS1, cdaPS2, and cdaPS3). Mutants of S. roseosporus containing deletions of one or more of the NRPS genes have been trans-complemented with dptA, dptBC, and dptD by inserting these genes under the control of the ermEp* promoter into separate conjugal cloning vectors containing ϕC31 or IS117 attachment (attP int) sites; delivering the plasmids into S. roseosporus by conjugation from Escherichia coli; and inserting the plasmids site-specifically into the chromosome at the corresponding attB sites. This trans-complementation system was used to generate subunit exchanges with lptD and cdaPS3 and the recombinants produced novel hybrid molecules. Module exchanges at positions d-Ala8 and d-Ser11 in the peptide have produced additional novel derivatives of daptomycin. The approaches of subunit exchanges and module exchanges were combined with amino acid modifications of Glu at position 12 and natural variations in lipid side chain starter units to generate a combinatorial library of antibiotics related to daptomycin. Many of the engineered strains produced levels of novel molecules amenable to isolation and antimicrobial testing, and most of the compounds displayed antibacterial activities.

[1]  D. Cane,et al.  Selective protein-protein interactions direct channeling of intermediates between polyketide synthase modules. , 2001, Biochemistry.

[2]  M. Marahiel,et al.  Synthesis and derivatization of daptomycin: a chemoenzymatic route to acidic lipopeptide antibiotics. , 2004, Journal of the American Chemical Society.

[3]  Richard H. Baltz,et al.  Molecular Cloning and Physical Mapping of the Daptomycin Gene Cluster from Streptomyces roseosporus , 1998, Journal of bacteriology.

[4]  M. Rybak,et al.  Daptomycin – a novel antibiotic against Gram-positive pathogens , 2004, Expert opinion on pharmacotherapy.

[5]  C. Walsh,et al.  Hybrid nonribosomal peptide-polyketide interfaces in epothilone biosynthesis: minimal requirements at N and C termini of EpoB for elongation. , 2004, Chemistry & biology.

[6]  R. H. Baltz,et al.  Use of rpsL for dominance selection and gene replacement in Streptomyces roseosporus , 1997, Journal of bacteriology.

[7]  W. Aretz,et al.  Friulimicins: novel lipopeptide antibiotics with peptidoglycan synthesis inhibiting activity from Actinoplanes friuliensis sp. nov. I. Taxonomic studies of the producing microorganism and fermentation. , 2000, The Journal of antibiotics.

[8]  W. Herlihy,et al.  A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation. , 1987, The Journal of antibiotics.

[9]  F. T. Counter,et al.  A54145 a new lipopeptide antibiotic complex: microbiological evaluation. , 1990, The Journal of antibiotics.

[10]  Christopher J. Silva,et al.  Heterologous production of daptomycin in Streptomyces lividans , 2006, Journal of Industrial Microbiology and Biotechnology.

[11]  M. Marahiel,et al.  Nonribosomal peptides: from genes to products. , 2003, Natural product reports.

[12]  J. Alder,et al.  In Vitro Bactericidal Activities of Daptomycin against Staphylococcus aureus and Enterococcus faecalis Are Not Mediated by Inhibition of Lipoteichoic Acid Biosynthesis , 2003, Antimicrobial Agents and Chemotherapy.

[13]  J. Finn,et al.  Array synthesis of novel lipodepsipeptide. , 2003, Bioorganic & medicinal chemistry letters.

[14]  R. Arbeit,et al.  The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  M. Debono,et al.  Deacylation of A21978C, an acidic lipopeptide antibiotic complex, by Actinoplanes utahensis. , 1988, The Journal of antibiotics.

[16]  K. O'Brien,et al.  Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp. , 1992, Gene.

[17]  G. Challis,et al.  Substrate recognition by nonribosomal peptide synthetase multi-enzymes. , 2004, Microbiology.

[18]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Stachelhaus,et al.  Selective interaction between nonribosomal peptide synthetases is facilitated by short communication-mediating domains. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R McDaniel,et al.  Formation of functional heterologous complexes using subunits from the picromycin, erythromycin and oleandomycin polyketide synthases. , 2000, Chemistry & biology.

[21]  J. Finn,et al.  Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin. , 2003, Bioorganic & medicinal chemistry letters.

[22]  P. Solenberg,et al.  Applications of transposition mutagenesis in antibiotic producing streptomycetes , 1997, Antonie van Leeuwenhoek.

[23]  P. Wessels,et al.  Biosynthesis of acylpeptidolactones of the daptomycin type. A comparative analysis of peptide synthetases forming A21978C and A54145. , 1996, European journal of biochemistry.

[24]  Jason Micklefield,et al.  Structure, biosynthetic origin, and engineered biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor. , 2002, Chemistry & biology.

[25]  L. Gierasch,et al.  A well‐defined amphipathic conformation for the calcium‐free cyclic lipopeptide antibiotic, daptomycin, in aqueous solution , 2005, Biopolymers.

[26]  Vivian Miao,et al.  The lipopeptide antibiotic A54145 biosynthetic gene cluster from Streptomyces fradiae , 2006, Journal of Industrial Microbiology and Biotechnology.

[27]  R. Molloy,et al.  Enzymatic and chemical modifications of lipopeptide antibiotic A21978C: the synthesis and evaluation of daptomycin (LY146032). , 1988, The Journal of antibiotics.

[28]  Chaitan Khosla,et al.  Quantitative analysis of the relative contributions of donor acyl carrier proteins, acceptor ketosynthases, and linker regions to intermodular transfer of intermediates in hybrid polyketide synthases. , 2002, Biochemistry.

[29]  D. M. Berry,et al.  A54145, a new lipopeptide antibiotic complex: discovery, taxonomy, fermentation and HPLC. , 1990, The Journal of antibiotics.

[30]  H. Shapiro,et al.  Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus , 2003, Antimicrobial Agents and Chemotherapy.

[31]  F. Huber,et al.  The formation of daptomycin by supplying decanoic acid to Streptomyces roseosporus cultures producing the antibiotic complex A21978C , 1988 .

[32]  M. Kurz,et al.  Friulimicins: novel lipopeptide antibiotics with peptidoglycan synthesis inhibiting activity from Actinoplanes friuliensis sp. nov. II. Isolation and structural characterization. , 2000, The Journal of antibiotics.

[33]  P. Baker,et al.  Membrane-associated echinocandin B deacylase of Actinoplanes utahensis: purification, characterization, heterologous cloning and enzymatic deacylation reaction , 2000, Journal of Industrial Microbiology and Biotechnology.

[34]  J. Turner,et al.  Production of a novel polyketide through the construction of a hybrid polyketide synthase. , 1996, Gene.

[35]  R. H. Baltz,et al.  Mutants of Streptomyces roseosporus that express enhanced recombination within partially homologous genes. , 1996, Microbiology.

[36]  Fei Liu,et al.  Biosynthesis of epothilone intermediates with alternate starter units: engineering polyketide-nonribosomal interfaces. , 2003, Angewandte Chemie.

[37]  H. Naganawa,et al.  Laspartomycin, a new anti-staphylococcal peptide. , 1968, The Journal of antibiotics.

[38]  R. H. Baltz,et al.  Gene transfer and transposition mutagenesis in Streptomyces roseosporus: mapping of insertions that influence daptomycin or pigment production. , 1996, Microbiology.

[39]  B. Eisenstein.  Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections , 2004, Expert opinion on investigational drugs.

[40]  D. Cane,et al.  Assessing the balance between protein-protein interactions and enzyme-substrate interactions in the channeling of intermediates between polyketide synthase modules. , 2001, Journal of the American Chemical Society.

[41]  S. Lacks,et al.  Genetic and structural characterization of endA. A membrane-bound nuclease required for transformation of Streptococcus pneumoniae. , 1990, Journal of molecular biology.

[42]  R. Hancock,et al.  Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. , 2004, Chemistry & biology.

[43]  Christopher J. Silva,et al.  Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. , 2005, Microbiology.